SynthesisBMC cancer2021
Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety.
Wendy Bernhard et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
SynthesisBMC cancer2021
Wendy Bernhard et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.